RT Journal Article
T1 Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies.
A1 Gonzalez-Cantero, Alvaro
A1 Teklu, Meron
A1 Sorokin, Alexander V
A1 Prussick, Ronald
A1 González-Cantero, Jorge
A1 Martin-Rodriguez, Jose Luis
A1 Patel, Nidhi
A1 Parel, Philip M
A1 Manyak, Grigory A
A1 Teague, Heather L
A1 Rodante, Justin A
A1 Keel, Andrew
A1 Pérez-Hortet, Cristina
A1 Sanchéz-Moya, Ana I
A1 Jiménez, Natalia
A1 Ballester, Asunción
A1 Solis, Jorge
A1 Fernandez-Friera, Leticia
A1 Barderas, María G
A1 Gonzalez-Calvin, Jorge L
A1 Jaen, Pedro
A1 Playford, Martin P
A1 Dey, Amit K
A1 Gelfand, Joel M
A1 Mehta, Nehal N
AB Psoriasis is associated with a higher risk of liver diseases. We investigated the impact of hepatic steatosis (European cohort) and hepatic inflammation (United States cohort) on subclinical atherosclerosis. In the European cohort (n = 76 psoriasis participants and 76 controls), nonalcoholic fatty liver disease, assessed by the sonographic hepatorenal index, was more prevalent in psoriasis than in controls (61% vs. 45%; P = 0.04). Participants with psoriasis with nonalcoholic fatty liver disease had a higher prevalence of subclinical atherosclerosis (ultrasonographic presence of plaque in femoral or carotid arteries) than participants with psoriasis without nonalcoholic fatty liver disease (61% vs. 23%; P = 0.006) and controls with nonalcoholic fatty liver disease (61% vs. 32%; P
YR 2021
FD 2021-07-19
LK http://hdl.handle.net/10668/22319
UL http://hdl.handle.net/10668/22319
LA en
DS RISalud
RD Apr 8, 2025